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Background: Constitutive activation of Ras in immortalized bronchial epithelial cells increases electron transport
chain activity, oxygen consumption and tricarboxylic acid cycling through unknown mechanisms. We hypothesized
that members of the Ras family may stimulate respiration by enhancing the expression of the Vb regulatory subunit
of cytochrome c oxidase (COX).
Results: We found that the introduction of activated H-RasV12 into immortalized human bronchial epithelial cells
increased eIF4E-dependent COX Vb protein expression simultaneously with an increase in COX activity and oxygen
consumption. In support of the regulation of COX Vb expression by the Ras family, we also found that selective
siRNA-mediated inhibition of K-Ras expression in A549 lung adenocarcinoma cells reduced COX Vb protein
expression, COX activity, oxygen consumption and the steady-state concentration of ATP. We postulated that COX
Vb-mediated activation of COX activity may be required for the anchorage-independent growth of A549 cells as
soft agar colonies or as lung xenografts. We transfected the A549 cells with COX Vb small interfering or shRNA and
observed a significant reduction of their COX activity, oxygen consumption, ATP and ability to grow in soft agar
and as poorly differentiated tumors in athymic mice.
Conclusion: Taken together, our findings indicate that the activation of Ras increases COX activity and
mitochondrial respiration in part via up-regulation of COX Vb and that this regulatory subunit of COX may have
utility as a Ras effector target for the development of anti-neoplastic agents.
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Activating mutations of the Ras guanosine nucleotide-
binding proteins cause insensitivity to GTPase-activating
proteins (GAP) and are common genetic alterations of
human cancers [1]. Activated GTP-bound Ras family
members promote survival and proliferation in part by
increasing glucose uptake and flux into the synthesis of
ribose-5-phosphate and lactate [2-4]. Recently, constitu-
tive activation of Ras also has been found to increase
mitochondrial tricarboxylic acid (TCA) cycle activity and
oxygen consumption and to sensitize cells to the ATP-* Correspondence: jason.chesney@louisville.edu
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reproduction in any medium, provided the ordepleting and cytotoxic effects of electron transport per-
turbation using the complex I inhibitor rotenone [5].
These data suggested that activation of the Ras signalling
pathway in immortalized cells might increase reliance on
mitochondrial metabolism for energy and anabolism [6].
In support of this conclusion, disruption of mitochon-
drial function caused by loss of the mitochondrial tran-
scription factor A (TFAM) gene reduced tumorigenesis
in an oncogenic K-Ras-driven mouse model of lung can-
cer [7]. Additionally, elevated glycolytic flux into mul-
tiple mitochondrial TCA cycle products has been
observed in human lung tumors in vivo [8] and these
tumors commonly express mutated Ras [9]. Last, several
agents that selectively disrupt mitochondrial function
(termed mitocans) have been found to interfere with theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tumor growth [10,11]. Understanding the precise
mechanisms whereby Ras family members regulate
mitochondrial metabolism and the functional import-
ance of this metabolic effect for the tumor-forming po-
tential of Ras-transformed cells may yield new molecular
targets for the development of anti-cancer agents.
The mitochondrial electron transport chain consists of
four respiratory enzyme complexes that serve to create a
proton gradient [12]. Cytochrome c oxidase (COX), or
complex IV, is the terminal enzyme in the electron trans-
port chain which pumps protons from the matrix into
the intermembrane space forming an electrochemical
gradient across the inner mitochondrial membrane to
generate ATP [13]. COX functions to catalyze electron
transfer from cytochrome c to molecular oxygen via four
redox centers [14]. Although COX only has ~20% total
control over ATP synthesis [15], studies in vivo have indi-
cated that COX represents the rate-limiting step of the
electron transport chain [6]. COX is composed of thir-
teen different subunits [16,17] - subunits I-III are
encoded by the mitochondrial genome whereas the other







































































































Figure 1 Introduction of oncogenic H-RasV12 into immortalized huma
COX activity and oxygen consumption. hT/LT and H-RasV12 cells were e
analysis (A) and COX Vb mRNA expression by real-time RT-PCR (D). Densito
β-Actin expression was determined. Enzyme activity assays of COX (E) and
expressed as the mean± SD of three experiments. *p value < 0.05 comparenuclear subunits are synthesized as precursor proteins
and imported into the mitochondria where the complex
is assembled [19]. Within the thirteen subunit complex,
the nuclear-encoded subunit Vb serves a unique role in
the regulation of COX activity as this particular subunit
faces the matrix side and is sufficient to increase both
COX activity and oxygen consumption in HeLa cervical
adenocarcinoma cells [20]. Interestingly, the expression
of subunit Vb has been found to be increased in neoplas-
tic cells and to positively correlate with the progression
of cells from normal epithelia to invasive carcinoma [21].
These observations suggest that COX Vb not only may
serve as an essential regulatory subunit of COX but also
may be mediating the increase in mitochondrial metabol-
ism caused by activation of Ras [5].
In the current study, we demonstrate that introduction
of the activated H-RasV12 GTPase into immortalized bron-
chial epithelial cells increases COX Vb protein expression,
COX activity and oxygen consumption and that COX Vb
protein expression is required to maintain the high oxygen
consumption and ATP concentration of A549 lung adeno-
carcinoma cells that express oncogenic K-Ras. We also
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hT/LT              H-RasV12             A549
Figure 2 Selective inhibition of eIF4E reduces COX Vb protein
expression but has no effect on β-Actin protein expression.
hT/LT, H-RasV12 and A549 cells were transfected with transfection
reagent alone, control siRNA or siRNA specific for eIF4E for 48 hours
and then examined for eIF4E and COX Vb mRNA expression by
real-time RT-PCR (A) and COX Vb and β-actin protein expression
using Western blot analysis (B). Protein expression was quantified by
densitometric analyses (C) and expressed as percentage of
transfection reagent. Data are expressed as the mean± SD of three
experiments. * p value <0.05.
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xenograft growth in mice without affecting proliferation
in vitro. Taken together, these observations suggest that
COX may be an appropriate molecular target for the de-
velopment of anti-neoplastic agents.
Results
H-RasV12 increases COX Vb protein expression and
activity
To explore the potential regulation of COX by Ras, we
employed normal human bronchial epithelial cells that
had been immortalized with the telomerase catalytic
subunit and SV40 large T antigen (hT/LT cells) and then
transformed with H-RasV12 (H-RasV12) [22]. Initially, we
analyzed the hT/LT cells and H-RasV12 cells for H-Ras
protein expression by Western blot analysis and
observed a marked increase in both wild-type H-Ras
(lower band) and H-RasV12 which displays reduced elec-
trophoretic mobility [23] (upper band) (Figure 1A, B).
These data suggest that introduction of H-RasV12 may
activate a positive feedback loop that leads to increased
wild-type H-Ras expression. We then examined the cells
for COX Vb mRNA expression by real-time RT-PCR
and for protein expression by Western blot and
observed no increase in COX Vb mRNA (Figure 1D)
but an increase in COX Vb protein expression with the
introduction of H-RasV12 (Figure 1A, C). The introduc-
tion of H-RasV12 into the hT/LT cells simultaneously
increased COX activity (Figure 1E) and oxygen consumption
(Figure 1F). Given that the only genetic difference between
the immortalized hT/LT and H-RasV12-transformed cells
is the ectopic expression of H-RasV12, these results indi-
cate that activation of Ras increases or stabilizes protein
expression of COX Vb, stimulates COX activity and
increases oxygen consumption.
COX Vb protein expression is dependent on eukaryotic
translation initiation factor 4E (eIF4E) expression
Since H-RasV12 expression had no effect on COX Vb
mRNA but caused an increase in COX Vb protein ex-
pression, we postulated that H-RasV12 may increase the
efficiency of COX Vb mRNA translation. Activation of
Ras signalling can increase the binding of the Eukaryotic
Translation Initiation Factor 4E (eIF4E) to multiple
mRNAs either through MAPK activation of Mnk which
directly phosphorylates eIF4E or through the PI3K/
AKT/mTOR-mediated phosphorylation and inhibition
of inhibitory 4E binding proteins [24]. Although an in-
crease in eIF4E binding to the 5´,7-methylguanosine cap
structure of mRNAs stimulates the translation of all
cap-dependent mRNAs, lengthy, GC-rich and highly
structured 5´ UTRs can markedly reduce efficient RNA
unwinding by eIF4E. COX Vb has a long (266 bp), GC-
rich (56%) 5’-UTR and we thus examined theconsequences of selective siRNA-mediated eIF4E inhib-
ition on the induction of COX Vb protein expression
caused by H-RasV12 (Figure 2A-C). Whereas silencing of
eIF4E mRNA expression had no effect on COX Vb
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sion in the hT/LT-immortalized, H-RasV12-transformed
cells and K-RasS12 positive A549 lung adenocarcinoma
cells was reduced by transfection with the eIF4E siRNA
species (Figure 2B, C). Importantly, eIF4E siRNA trans-
fection had no effect on β-actin protein expression,
which contains a short non-complex 5’-UTR, in any of
the three cell types examined (Figure 2B, C). These data
indicate that COX Vb protein expression is dependent
on eIF4E activity and that the observed increase in COX
Vb caused by introduction of oncogenic Ras can be par-
tially attenuated by selective inhibition of eIF4E.
Selective inhibition of K-Ras suppresses COX Vb activity,
oxygen consumption and intracellular ATP in A549 cells
We next selectively inhibited the expression of K-Ras in
A549 cells using siRNA and examined the consequences
on COX Vb protein expression, COX activity, oxygenFigure 3 Selective inhibition of K-Ras expression by A549 lung adeno
ATP. A549 cells were transfected with transfection reagent (TR) alone, cont
for COX Vb protein expression (A and B), COX Vb mRNA expression (C), CO
expressed as the mean± SD of three experiments. * p value <0.05.consumption and ATP concentration. Transfection of
A549 cells with K-Ras siRNA caused a reproducible re-
duction in COX Vb protein expression (Figure 3A, B)
without affecting COX Vb mRNA expression (mRNA
fold change of K-Ras siRNA relative to control siRNA=
1.01 ± 0.12) (Figure 3C).
Selective K-Ras inhibition also reduced COX activity,
oxygen consumption and the steady-state concentration
of ATP in the A549 cells (Figure 3D-F). These data
coupled to the observations that ectopic expression of
H-RasV12 increases COX Vb expression and COX activ-
ity further support the conclusion that COX Vb expres-
sion is regulated by Ras signalling.
Suppression of COX Vb expression decreases anchorage-
independent growth as soft agar colonies
In order to directly examine the hypothesis that COX
Vb expression is required for tumor growth, we nextcarcinoma cells reduces COX activity, oxygen consumption and
rol siRNA or siRNA specific for K-Ras for 72 hours and then examined
X activity (D), oxygen consumption (E) and ATP (F). Data are
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siRNA species specific for the open reading frame (Vb1)
or for the 3’-untranslated region (Vb2). Forty eight hours
after transfection, Western blot analyses indicated that
both COX Vb siRNA species inhibited the protein ex-
pression of COX Vb (Figure 4A, B). We found that
transfection of A549 cells with either COX Vb siRNA
decreased COX activity, oxygen consumption, intracellu-
lar ATP and the NAD+/NADH ratio compared to con-
trols (cells, transfection reagent alone or control siRNA)
(Figures 4C-F). We next sought to assess the conse-
quences of reduced mitochondrial metabolism on
anchorage-independent survival and growth in soft agar.
We observed no significant decrease in A549 anchorage-
dependent cell proliferation 48 hours after transfection
with COX Vb-specific siRNA molecules (Figure 5A) but
found that the siRNA-mediated silencing of COX Vb





















































Figure 4 Selective inhibition of COX Vb by A549 cells reduces COX ac
with transfection reagent alone, control siRNA or siRNA specific for the ORF
COX Vb protein expression (A and B), COX activity (C), oxygen consumptio
mean± SD of three experiments. * p value <0.05.formation and growth (Figure 5B, C). Although the pre-
cise metabolic explanation for the apparent sensitivity of
soft agar colony growth to COX Vb inhibition is not
well understood, nutrient and oxygen diffusion limita-
tions imposed by adjacent cells within the colony com-
bined with reduced COX activity may cause synergistic
cytostasis.
Suppression of COX Vb expression decreases anchorage-
independent growth as tumors in athymic mice
The ability to grow as soft agar colonies can be predict-
ive of tumor-forming capacity in athymic mice. We sub-
cutaneously injected 5 × 106 live A549 cells stably
transfected with a plasmid expressing the COX Vb1
shRNA or a control shRNA and measured tumor out-
growth using microcalipers. Suppression of COX Vb
protein expression in the COX Vb1 shRNA clone was














































































tivity, oxygen consumption and ATP. A549 cells were transfected
(Vb1) or 3’-UTR (Vb2) of COX Vb for 48 hours and then examined for
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Figure 5 Selective inhibition of COX Vb expression by A549 cells suppresses anchorage-independent growth in soft agar. A. 105 A549
cells transfected with COX Vb or control siRNA were cultured for 48 hours and viable cells were enumerated using light microscopy. B. After the
48 hour transfection, A549 cells were plated on 6 cm dishes containing DMEM with 0.6% agar. Cells were fed with 0.2% agar in media every
three days. After 21 days, soft agar colonies were enumerated. C. Representative photomicrographs of the soft agar colonies. Data are expressed
as the mean± SD of five (A) and three (B) experiments. * p value <0.05.
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tumors after 4 weeks, the outgrowth of the COX Vb1
shRNA expressing tumors was markedly reduced over
the following 3 weeks (Figure 6B). We then euthanized
the mice, excised the tumors and stained them with
Hematoxylin and Eosin (Figure 6C-H). We found that
the control A549 tumors contained large areas of tumor
necrosis (see white arrows, Figure 6D), pleomorphic nu-
clei (black arrows, Figure 6E) and numerous mitotic fig-
ures (white arrows, Figure 6E), all of which are
consistent with high-grade, rapidly growing but poorly
differentiated adenocarcinomas. In contrast, we observed
no tumor necrosis, low mitotic activity, and few pleo-
morphic nuclei in the COX Vb1 shRNA-transfected
A549 tumors (Figure 6F-H), indicating that COX Vb in-
hibition in the A549 cells significantly lowered the histo-
pathological grade of tumors in vivo. Given that COX
Vb inhibition reduces oxygen consumption in vitro, we
speculated that the oxygen concentration may be
increased in the COX Vb shRNA A549 tumors relative
to the control tumors. However, we examined thetumors for carbonic anhydrase IX protein expression,
which is a target gene of HIF-1α, and observed no differ-
ence in expression (data not shown).
Discussion
In this study, we found that introduction of oncogenic
H-RasV12 into immortalized human bronchial epithelial
cells enhanced eIF4E-dependent COX Vb protein ex-
pression, COX activity and oxygen consumption. Con-
versely, selective siRNA silencing of K-Ras expression in
A549 cells was observed to selectively suppress COX Vb
protein expression, COX activity and oxygen consump-
tion. Transfection of the A549 cells with two independ-
ent siRNA molecules specific for COX Vb caused a
marked decrease in COX activity, oxygen consumption,
ATP, anchorage-independent soft agar colony growth
and xenograft growth in athymic mice. Taken together,
these data suggest that a metabolic regulatory pathway
thus exists whereby Ras signalling activates eIF4E activ-
ity which, in turn, leads to increased COX Vb protein

































Figure 6 Stable COX Vb shRNA expression in A549 cells reduces the outgrowth of A549 xenografts and inhibits multiple
histopathological indicators of poor differentiation in athymic mice. 5x106 A549 cells stably transfected with control or COX Vb-specific
shRNA were subjected to Western blot analysis for COX Vb or β-actin expression (A) and then injected subcutaneously into athymic mice. After
4 weeks, tumors were measured weekly for a total of 3 additional weeks (timepoints 0, 7, 14 and 21) using microcalipers. Tumor mass was
calculated based on bidimensional measurements and data are expressed as the mean± SEM of two experiments (B). After 7 weeks of growth,
mice were euthanized and tumors were excised, fixed in formalin, paraffin-embedded, sectioned and stained with hematoxylin/eosin. Light
micrographs demonstrate that, relative to the COX Vb1 shRNA-transfected A549 tumors (F-H), the control A549 tumors were higher grade, poorly
differentiated and invasive (C-E), contain large areas of tumor necrosis (D; white arrows), pleomorphic nuclei (E, black arrows), and numerous
mitotic figures (E, white arrows).
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Vb inhibition was associated with reduced histological
markers of high-grade poorly differentiated cells which
may indicate that COX activity is required for the
aggressiveness of certain lung adenocarcinomas. These
observations support an examination of potential corre-
lations between COX Vb protein expression by human
lung adenocarcinomas and clinical outcomes includinggrowth rates, response to therapy and overall survival.
Additionally, these results indicate that COX may have
utility as a target for the development of anti-cancer
therapeutics, especially against tumors in which the Ras
signalling pathway is activated.
Ras proto-oncogenes encode membrane-bound
21 kDa guanosine nucleotide-binding proteins that
transduce mitogenic signals from tyrosine-kinase
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of human cancers [9], activation of Ras signalling path-
ways (e.g. via epidermal growth factor receptor [EGFR]
amplifications) is a nearly ubiquitous characteristic of
human cancers. K-RasG12D transgenic mice develop
tumors which express COX Vb [25], and activation of
the Ras/cAMP/protein kinase A pathway in Saccharo-
myces cerevisiae increases COX activity and oxygen con-
sumption [26]. Additionally, the ratio of COX Vb to
COX I or COX II expression markedly increases during
the progression from normal human prostate epithelium
to invasive prostate carcinoma [21], a transformation
that is dependent on the downstream Ras signalling
pathways MAPK and PI3K/AKT [27]. The current study
adds to this body of literature, demonstrating that the
discrete introduction of the human oncogene H-RasV12
into immortalized human bronchial epithelial cells not
only increases protein expression of the regulatory Vb
subunit but also oxygen consumption and COX activity.
Perhaps more importantly, the current study demon-
strates for the first time that COX Vb expression by
Ras-transformed lung adenocarcinoma cells is required
for their ability to grow as a high-grade, poorly differen-
tiated tumor in athymic mice.
We previously reported that introduction of activated
Ras into immortalized cells simultaneously increased
glycolytic flux to lactate, TCA cycle activity and oxygen
consumption [5]. Ras oncoproteins also directly increase
the expression of uncoupling protein (UCP)-1, and
UCP-2 expression has been found to be increased in
most human colon adenocarcinomas in which up to
60% contain K-Ras mutations [28,29]. The mitochondrial
TCA cycle and cytoplasmic GADPH reactions require
oxidized NAD+which is produced by LDH in the cyto-
sol or by electron transport chain activity in the mito-
chondria. We postulate that Ras activation may cause
simultaneous stimulation of COX activity and uncoup-
ling of ATP synthase from the proton gradient in order
to facilitate the continued oxidation of NADH to NAD+
necessary for glycolytic flux and TCA cycling [6].
Expression of oncogenic H-RasV12 sensitizes immorta-
lized cells to electron transport chain disruption with
rotenone suggesting that activation of Ras signalling also
may confer greater reliance on the electron transport
chain for energy requirements [5]. Given that we have
found that introduction of H-RasV12 increases COX Vb
protein expression and COX activity relative to immor-
talized cells, we speculate that the COX Vb subunit and
the entire COX complex serve as essential metabolic
downstream effectors of Ras. Dichloroacetate (DCA), an
inhibitor of pyruvate dehydrogenase (PDH) kinase and
thus a stimulator of PDH and flux into the TCA cycle,
has been observed to increase oxygen consumption but
to reduce tumor growth [30]. In contrast, we have foundthat selective inhibition of COX Vb reduced both oxy-
gen consumption and tumor growth. Although the pre-
cise mechanism and rationale for these differences are
not well understood, we postulate that the disruption of
NADH oxidation caused by either the diversion of pyru-
vate away from LDH or by the inhibition of electron
transport chain activity (Figure 4F) may yield a similarly
deleterious effect on anabolic pathways such as the TCA
cycle that are required for tumor growth.
Conclusion
In conclusion, we find that activation of the Ras signal-
ling pathway increases COX activity in part via eIF4E-
dependent enhancement of COX Vb protein expression
and that COX is required for tumorigenic growth. The
continued characterization of the regulatory mechanisms
and rationale for increased COX activity in transformed
cells should allow us to tailor rational anti-metabolic
approaches for the treatment of cancer.
Methods
Cell lines and culture
A549 human lung adenocarcinoma cells (American Type
Culture Collection, Manassas, VA) were maintained in
Dulbecco’s Modified Eagle Medium (DMEM, Invitrogen,
Grand Island, NY) supplemented with 10% FCS and
gentamicin sulfate (HyClone, Logan, UT). Normal
human bronchial epithelial cells expressing telomerase
and SV40 large T antigen (hT/LT) and activated Ras
(H-RasV12) were gifts from Dr. B. J. Rollins, Dana Farber
Cancer Institute. hT/LT and H-RasV12 cells were grown
in BEGM medium formulated with SingleQuots (bovine
pituitary extract, recombinant human epidermal growth
factor, hydrocortisone, insulin, epinephrine, tri-iodothyr-
onine, transferrin, gentamicin, amphotericin B and retin-
oic acid) (Lonza, Walkersville, MD). Media contained
physiologic glucose (5.5 mM) and glutamine (1 mM),
and cells were cultured under 21% O2 (normoxia) with
5% CO2 at 37°C (Heraeus).
siRNA transfections
Cells were plated at 8 x 104 cells/well in 6 well tissue
culture plates and incubated at 5% CO2 and 37°C in
DMEM as described above for 24 hours. Cells were then
transfected with siRNA using RNAiMax (Invitrogen,
Carlsbad, CA) according to the manufacturer’s protocol.
For inhibition of COX Vb in A549 cells, two siRNA con-
structs were designed, one specific for the open reading
frame region of COX Vb (COX Vb- ORF) and a second
specific for the 3’ untranslated region (COX Vb-
3’UTR), termed COX Vb1 and COX Vb2 respectively.
The target sequences (sense strands) were as follows:
Vb1 =AGUAGGCUGCAUCUGUGAA and Vb2 =
CAGUAAAGACUAGCCAUUG. siRNAs against lamin
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COX Vb siRNA duplexes were synthesized by Dharma-
con (Lafayette, CO). For the inhibition of eIF4E, hT/LT,
H-RasV12 or A549 cells were transfected with pre-
synthesized eIF4E siRNA (Ambion, Austin, TX). For the
inhibition of K-Ras, A549 cells were transfected with
pooled K-Ras siRNA (Santa Cruz Biotechnology, Santa
Cruz, CA).Western blot analysis
Western blot analysis was carried out on protein lysates
from A549, hT/LT, and H-RasV12 cells transfected with
siRNA as described above. Briefly, equal amounts of
total protein (30 μg) from each sample were run on a 4-
20% gradient SDS-PAGE gel under reducing conditions
and proteins were transferred to PVDF membranes
(BioRad, Hercules, CA). Membranes were probed with a
1:500 dilution of anti-COX Vb polyclonal mouse anti-
body (Invitrogen), a 1:1000 dilution of anti-H-Ras anti-
body or a 1:100 dilution of anti-K-Ras antibody (both
from Santa Cruz). Immunoreactive proteins were visua-
lized by incubating membranes with horseradish
peroxidase-conjugated anti-mouse or anti-rabbit IgG
antibody (1:10000) followed by reaction with ECL Plus
(Amersham, St. Louis MO). Membranes were subse-
quently probed with a mouse monoclonal β-actin anti-
body (Sigma, St. Louis MO) as an internal protein
loading control. Experiments were repeated four times.
All data are expressed as the mean ± SD of three experi-
ments. Statistical significance was assessed by the un-
paired two-tail T-test.COX activity assay
COX activity was measured as described in Campian
et al. [20]. Briefly, lysates of cells (at a concentration of
2 × 106 cells/ml) were prepared in 0.25 M sucrose,
40 mM potassium chloride, 2 mM EGTA, 1 mg/ml bo-
vine serum albumin, and 20 mM Tris–HCl (pH 7.2) and
disrupted by 3 1 second bursts using a microtip Fisher
model 100 sonic dismembrator at scale 3 (on a scale of
0–10 of the 100-watt maximum power output) (Fisher
Scientific, Pittsburgh, PA). The lysate was centrifuged at
4000 × g for 10 min, the pellet discarded and the super-
natant was used for COX assays. Assays contained 30 μg
of protein and were performed at 37°C in 200 μl reaction
volumes. The assay involved the addition of 40 μM fer-
rocytochrome c in an isosmotic medium (10 mM
KH2PO4 (pH 6.5), 1 mg/ml bovine serum albumin,
0.3 M sucrose) containing 2.5 mM n-dodecyl maltoside
to permeabilize mitochondrial membranes. The activity
was calculated from the rate of decrease in absorbance
of ferrocytochrome c at 550 nm (ε= 19.1 mM–1 cm–1).
All data are expressed as the mean ± SD of threeexperiments. Statistical significance was assessed by the
unpaired two-tail T-test.
Oxygen consumption
Cells were detached with trypsin-EDTA and centrifuged
at 1000 rpm for 5 minutes in complete culture medium.
Oxygen consumption was measured using a Strathkelvin
782 Oxygen Meter (Strathkelvin Instruments, Glasgow,
Scotland, UK). Respiration rates were measured using 1 ×
106 cells suspended in a total volume of 525 μL DMEM
containing 10% FBS at 37°C for 10 minutes. A starting O2
concentration of 240 μM was assumed based on O2 solu-
bility at conditions in this laboratory (1 atm/37°C). Experi-
ments were repeated four times. The data shown are
mean±SD of three experiments. Statistical significance
was assessed by the unpaired two-tail T-test.
ATP assay
Cells were washed (while still adherent) with cold PBS
x1, lysed with passive lysis buffer (1X, Molecular Probes,
Invitrogen) added directly to the plates and immediately
harvested by scraping. The lysates were flash frozen (to
−80°C) and thawed (to 37°C) once to accomplish
complete lysis and then centrifuged (at 4°C) for 30 sec-
onds to clear the lysates. Intracellular ATP levels were
determined using a bioluminescence assay (Molecular
Probes) utilizing recombinant firefly luciferase and its
substrate, D-luciferin. The luminescence was read in a
TD-20/20 luminometer (Turner Designs, Sunnyvale,
CA) at 560 nm. The ATP values were calculated using
an ATP standard curve. The protein concentrations of
the lysates were estimated using the bicinchoninic acid
(BCA) assay (Pierce Biotechnology, Rockford, IL) and
ATP was expressed as nmol per mg protein. Experi-
ments were repeated five times. All data are expressed
as the mean ± s.d. of three experiments. Statistical sig-
nificance was assessed by the unpaired two-tail T-test.
NAD+/NADH ratio assay
A549 cells treated with siRNA species for 48 hours were
lifted using trypsin - EDTA, washed twice with cold PBS
and 105 cells were pelleted by centrifugation. NAD+ and
NADH concentrations were measured using an enzyme-
based assay (E2ND-100, Bioassay Systems, Hayward,
CA). Briefly, the cell pellets were homogenized in either
NAD+ extraction buffer (containing 0.40% HCl) or
NADH extraction buffer (containing 0.40% NaOH),
extracts heated to 60°C and then assay buffer (containing
Tris(hydroxymethyl)aminomethane 3.0%, and BSA
0.10%) and extraction buffer (to neutralize the extracts)
were added. Following centrifugation, supernatants were
mixed with working reagent containing assay buffer, lac-
tate dehydrogenase, diaphorase, lactate and tetrazolium
dye (MTT) and optical density at 565 nm was recorded
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reader spectrophotometer. The difference in absorbance
was compared with standard solutions and used to cal-
culate NADH and NAD+ concentrations. All data are
expressed as the mean ± s.d. of three experiments. Statis-
tical significance was assessed by the unpaired two-tail
T-test.
Cell viability
For measurements of contact-dependent growth, cells
were grown in appropriate media as described above.
Following siRNA transfections, cells were grown for
48 h. Proliferation was determined using trypan blue ex-
clusion. Cells were incubated in 20% trypan blue (Sigma)
for 5 minutes. Cells excluding trypan blue were counted
using a standard hemocytometer (Hausser Scientific) to
determine the total number of viable cells. All data are
expressed as the mean± SD of five experiments. Statis-
tical significance was assessed by the unpaired two-tail
T-test.
Soft agar colony formation assay
A549 cells with or without Vb siRNA transfection for
48 hours were plated at a density of 1 × 104 cells/60-mm
plate sandwiched by 3 ml bottom agar (0.6 %) and 3 ml
top agar (0.3%). Cells were fed every three days by add-
ing a new layer of top agar. After 21 days, colonies were
counted in random 1 cm2 sections of each plate. All data
are expressed as the mean ± SD of three experiments.
Statistical significance was assessed by the unpaired two-
tail T-test.
Xenograft studies
A549 lung adenocarcinoma cells stably transfected with
either COX Vb or a control shRNA were collected from
exponential growth phase culture in DMEM supplemented
with 10% FCS. Cells were washed twice and re-suspended
in PBS (5 × 107 cells/ml). Groups of CD1 female athymic
mice (20 gm) were injected s.c. with 0.1 ml of the cell
suspension (5 × 106 cells). The tumors were followed
from the time of appearance until 21 days. Tumor
masses were determined in a blinded fashion with
Vernier calipers according to the following formula:
mass(mg) = (width, mm)2 × (length, mm)/2 [31]. All data
are expressed as the mean± SD of two experiments
(n = 8 per group). Statistical significance was assessed by
the unpaired two tail T-test. At the end of the experi-
ment, mice were euthanized and the tumors were
excised, fixed in formalin, embedded in paraffin and
stained with Hematoxylin and Eosin or with anti-CA IX
(Abcam, Cambridge, MA).
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